CITADEL ADVISORS LLC

Position in HYPD — Hyperion Defi, Inc.

CIK 1423053 MIAMI, FL

Back to HYPD Full portfolio

Position in HYPD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$176,778

-$212,747 QoQ

Shares Held

56,299

-50.1% QoQ

Ownership

0.362%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#12

of 33 holders

Holding Since

Mar 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in HYPD Over Time

Shares Held

Position Value (USD)

Derivatives in HYPD

reported options exposure · as of Mar 31, 2025

CallValue

$577

CallShares

525

PutValue

$2,559

PutShares

2,327

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. HYPD ranks #326 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

All Filings in HYPD

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$176,778	56,299	-50.1%	Shares	Defined	2026-08-14
2026-03-31	$389,525	112,906	+563.2%	Shares	Defined	2026-05-15
2025-12-31	$60,609	17,025	+38.9%	Shares	Defined	2026-02-17
2025-03-31	$577	525	—	Call	Defined	2025-05-15
2025-03-31	$13,484	12,259	—	Shares	Defined	2025-05-15
2025-03-31	$2,559	2,327	—	Put	Defined	2025-05-15
No filing history on record for this holder in this stock.